Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 25 of 58, showing 10 Applications out of 576 total, starting on record 241, ending on 250

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

241.

ECCT/20/06/07   Quality of Oxytocin and TXA
    Quality of Oxytocin and Tranexamic acid in selected facilities in six countries   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Mbagathi County Hospital (Nairobi City county)
9. Kakamega County Government Referral Hospital (Kakamega county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
19-10-2020 View

242.

ECCT/20/07/02   RV 460 HIV Vaccine Trial
    A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of   Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an   Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted   HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine   in Healthy HIV Uninfected Adults in Kenya   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
KEMRI/US MRDA-A/K, KERICHO
 
19-10-2020 View

243.

ECCT/20/09/04   Pharmacy PrEP Delivery
    Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot Study   
Principal Investigator(s)
1. Prof. Elizabeth Bukusi
Site(s) in Kenya
1. PHRDTHIKA (Kiambu county)
2. Kisumu Site (Kisumu county)
 
27-10-2020 View

244.

ECCT/20/09/01   PrEP in Pharmacy - PILOT STUDY
    Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot study       
Principal Investigator(s)
1. Kenneth Kairu Ngure
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
28-10-2020 View

245.

ECCT/20/08/01   CorNeat EverPatch
    The CorNeat EverPatch – A First-In-Human Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts       
Principal Investigator(s)
1. Lily Adhiambo Nyamai
Site(s) in Kenya
1. Lions SightFirst Hospital (Nairobi City county)
2. Kenyatta National Hospital (Nairobi City county)
3. Kwale Eye Centre (Kwale county)
 
10-11-2020 View

246.

ECCT/20/08/04   LOW DOSE RADIATION THERAPY
    A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) in the treatment of severe Covid 19 pneumonia patients on (or requiring) mechanical ventilatory support   
Principal Investigator(s)
1. PROF. MANSOOR SALEH
Site(s) in Kenya
Aga Khan University Hospital, Nairobi
 
11-11-2020 View

247.

ECCT/20/10/01   HIV-CORE 006
    A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa.    
Principal Investigator(s)
1. Eduard J Sanders
Site(s) in Kenya
1. KEMRI Mtwapa Research Clinic (Kilifi county)
2. KAVI-ICR Nairobi (Nairobi City county)
 
19-11-2020 View

248.

ECCT/20/10/02   MALCOV
    Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso (MALCOV)   
Principal Investigator(s)
1. Simon Kariuki
2. Helen Barsosio
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOORTH), (Kisumu county)
2. Kisumu County Referral Hospital. (Kisumu county)
3. Alupe sub-County Hospital, (Busia county)
4. Bondo sub-County Hospital, (Siaya county)
5. Macalder (Nyatike) sub-County Hospital (Migori county)
6. Migori County Teaching and Referral Hospital; (Migori county)
 
23-11-2020 View

249.

ECCT/20/09/02   BEe-HIVe
     B-ENHANCEMENT OF HBV VACCINATIONIN PERSONS LIVING WITH HIV (BEe-HIVe) EVALUATION OF HEPLISAV-B,A5379   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
KEMRI/KERICHO CLINIC RESEARCH CENTRE
 
27-11-2020 View

250.

ECCT/20/07/03   STAND
    A Phase III multicenter, randomized, double blind study to assess efficacy and safety of two doses of crizanlizumab verses placebo, with or without hydroxyurea/hydroxycarbamide therapy in adolescent and adult sickle cell disease patients with Vaso-Occlusive Crises (STAND)   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
1. CREATES Strathmore University (Nairobi City county)
2. Getrudes Childrens Hospital (Nairobi City county)
3. International Cancer Institute (Elgeyo/Marakwet county)
 
30-11-2020 View